MedPath

A Study to Estimate the Prevalence of dental problems in Type 1 and Type 2 Diabetic and Non-Diabetic Patients

Recruiting
Conditions
Periodontitis
Registration Number
CTRI/2012/06/002748
Lead Sponsor
max super speciality hospital
Brief Summary

Estimation of the prevalence periodontitis in type1 and type 2 diabetic patients as compared with non-diabetic patients

The hypothesis beingtested is:

 H0: pT= pC vs. H1: pT ≠ pC

      Where pT and pC   are theproportion of depression in diabetes and non diabetes groups respectively,rejection of the null hypothesis at a two sided significance level of 0.05indicates a significant difference between two arms

Detailed Description

Not available

Recruitment & Eligibility

Status
Open to Recruitment
Sex
All
Target Recruitment
60
Inclusion Criteria
  • case inclusion criteria 1)Subject aged over 18 years old.
  • 2)Patients having diagnosis of type 1 or type 2 diabetes as defined by American Diabetes Association (ADA 2011) criteria.
  • 3)Subject able to provide consent to participate in the study.
  • CONTROL Inclusion Criteria 1)Males and females of age between 18-80.
  • 2)Absence of diagnosed type 1 and type 2 diabetes mellitus or any history of diabetes i.e. HbA1c level< 6.5 3)Subject able to provide consent to participate in the study.
Exclusion Criteria
  • CASE Exclusion Criteria: Patient with recent periodontal treatment for atleast 3 months.
  • CONTROL Exclusion Criteria Pregnant or lactating women.

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Presence of periodontitis in type 1and type 2 diabetic and non-diabetic patients2 months
Secondary Outcome Measures
NameTimeMethod
no secondary outcomen/a

Trial Locations

Locations (1)

Max Super Speciality Hospital

🇮🇳

Delhi, DELHI, India

Max Super Speciality Hospital
🇮🇳Delhi, DELHI, India
Dr sujeet jha
Principal investigator
8826655872
sujeet.jha@maxhealthcare.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.